Track key external and internal signals that may affect commercialization assumptions, including clinical readouts, regulatory milestones, competitive events, access dynamics, customer feedback, and market structure changes. COMPANY OVERVIEW: Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases.